National Institutes of Health Clinical Center (CC)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institutes of Health Clinical Center (CC) sits in the top decile of US sponsors by registered trial count (#107 of 15,742 sponsors by registered trial count).
National Institutes of Health Clinical Center (CC): 338 sponsored US clinical trials, 22 recruiting.
National Institutes of Health Clinical Center (CC) sponsors 338 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 272 completed. 17 of these trials are in Phase 3-4 (later-stage) and 121 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 8 trials.
Top-decile sponsor footprint
National Institutes of Health Clinical Center (CC) ranks in the top decile of sponsors by registered trial count (#107 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
272 of 308 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
338 total, page 6 of 7
CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy
NCT00031941
Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or Narcotics
NCT00032682
ABT-751 in Treating Young Patients With Refractory Solid Tumors
NCT00036959
Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
NCT00031291
Study of Transfusion-Transmitted Infections
NCT00023023
Process and Outcomes of Pain Management
NCT00028249
Morbidity After Diagnosis and Treatment of Breast Cancer Patients
NCT00027118
Implementing the Assent Requirement for Research With Children
NCT00102076
Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer
NCT00027105
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy
NCT00030108
Technology Dependency and Health-Related Quality of Life
NCT00022984
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
NCT00021047
Tipifarnib in Treating Young Patients With Refractory Leukemia
NCT00022451
Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus
NCT00015639
Study of Tongue Pressures
NCT00013832
Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver
NCT00020501
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT00020579
The Effect of Milk Thistle on the Pharmacokinetics of Indinavir
NCT00011635
Effect of Ginkgo Biloba on Phenytoin Elimination
NCT00011063
Platelet Function in Patients Treated With SSRI and Non-SSRI Antidepressants
NCT00009568
Effects of Kava on the Body's Elimination of Caffeine and Dextromethorphan
NCT00009542
Nitric Oxide to Improve Blood Flow in Sickle Cell Disease
NCT00009581
Structure and Function of the Human Tongue
NCT00007137
Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers
NCT00006395
Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women
NCT00559039
Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
NCT00020345
Role of Prostaglandins in the Regulation of Brain Blood Flow
NCT00006318
Magnetic Resonance Imaging for Evaluating Kidney Function
NCT00006173
Spleen Size in Peripheral Blood Stem Cell Donors
NCT00006148
Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer
NCT00020098
Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
NCT00020124
Endothelial Cell Dysfunction in Pulmonary Hypertension
NCT00098072
Quality of Life in Patients With Chronic Ischemic Heart Disease
NCT00005671
Brain Processing of Language Meanings
NCT00005004
Study of Fetal Swallowing
NCT00004566
Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer
NCT00020046
A Study of Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral Therapy
NCT00001948
Comparison of Magnetic Resonance Angiography and Standard Angiography in Diagnosing Atherosclerosis
NCT00001946
Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV
NCT00004846
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
NCT00004994
Study of New Magnetic Resonance Methods
NCT00001844
Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide)
NCT00001845
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2
NCT00019812
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
NCT00019786
Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00019747
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
NCT00019643
G-CSF for Granulocyte Donation
NCT00001842
Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
NCT00019760
Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies
NCT00004851
A Family Study of Adults With Glioma
NCT00339352
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 74 |
| Phase 2 | 47 |
| Phase 3 | 6 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the National Institutes of Health Clinical Center (CC) pipeline
22 recruiting of 338 indexed (7% open); 272 completed (80%).
Phase mix: 17 late (III/IV) vs 121 early (I/II) (early-phase heavy).
Top condition: Healthy (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institutes of Health Clinical Center (CC): open-pipeline peers nationwide
Peers matched on 338 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
National Institutes of Health Clinical Center (CC) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 338 trials (± recruiting share)
- Cedars-Sinai Medical Center · 339 trials · 21% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- National Institute on Drug Abuse (NIDA) · 335 trials · 4% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Alliance for Clinical Trials in Oncology · 7% recruiting · 446 trials
- NICHD Neonatal Research Network · 7% recruiting · 61 trials
- Insmed Incorporated · 6% recruiting · 31 trials
- Baylor Breast Care Center · 7% recruiting · 15 trials
Related
What to do with this National Institutes of Health Clinical Center (CC) page
338 registered trials is a research-attention snapshot, not an endorsement of National Institutes of Health Clinical Center (CC) or any single study.
- 22 of National Institutes of Health Clinical Center (CC)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institutes of Health Clinical Center (CC) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. National Institutes of Health Clinical Center (CC) pipeline card: 338 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.